USPTO serial 75094773
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Belinda I. Berman
BELINDA I BERMAN WARNER-LAMBERT COMPANY201 TABOR RDMORRIS PLAINS, NJ 07950UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for use in the treatment of cardiovascular disorders and cholesterol reduction | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 4, 1998 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Dec 8, 1997 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 11, 1997 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 10, 1997 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 10, 1997 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 1996 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Sep 12, 1996 | DOCK | ASSIGNED TO EXAMINER | — |